Novartis AG
NYSE:NVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
NYSE:NVS
|
CH |
|
Pivotree Inc
XTSX:PVT
|
CA |
|
E
|
EPIC Acquisition Corp
AEX:EPIC
|
UK |
|
AC Energy Corp
OTC:ACPIF
|
PH |
|
G
|
Galderma Group AG
SIX:GALD
|
CH |
Wall Street
Price Targets
NVS Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for
NVS
is 163.23 USD
with a low forecast of 118.19 USD and a high forecast of 243.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NVS's stock price target?
Price Target
163.23
USD
According to Wall Street analysts, the average 1-year price target for
NVS
is 163.23 USD
with a low forecast of 118.19 USD and a high forecast of 243.05 USD.
What is Novartis AG's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Novartis AG's revenue is
0%.
The projected
CAGR
for the next 3 years is
5%.
What is Novartis AG's Operating Income forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Novartis AG's operating income is
4%.
The projected
CAGR
for the next 3 years is
9%.
What is Novartis AG's Net Income forecast?
Projected CAGR
14%
For the last 14 years the
compound annual growth rate for
Novartis AG's net income is
3%.
The projected
CAGR
for the next 3 years is
14%.
